
The Chinese community group-buying app Nice Tuan, backed by the ecommerce giant Alibaba, was handed a 1.5 million yuan (US$235,000) fine by China’s market regulator for failing to take action over product dumping practices and pricing fraud.
The State Administration for Market Regulation (SAMR) also ordered the platform to suspend its business operations in the Jiangsu province for three days starting Friday, May 28, for “failing to rectify” monopolistic behaviour.
The organization released a statement on Thursday saying that this was the first time the SAMR issued a fine higher than the basic penalty, “demonstrating the determination of the market supervision department to fight the chaos.”
A spokesperson for the organization added that “in late April, we received clues that Nice Tuan did not fully implement the rectification commitments and there are still large numbers of low-price dumping and price fraud incidents in its Jiangsu area.”
Community group-buying platforms offer groceries at a lower price for people who join together to buy in bulk directly from the farmer. The model has become increasingly popular in China, especially in lower-tier cities. However, competition is intense among platforms that are often accused of manipulating prices unfairly.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas